Healthcare Professionals' Perceptions on Advances in Digital Health Devices for Growth Hormone Therapy: Clinical Expert Panel Discussion in the UK and France

Abstract

Assessing healthcare professionals' (HCPs') perceptions on the appropriateness, ease of use and reliability of connected digital health technologies can help to understand acceptance and their recommendations to patients/caregivers for personalization of growth hormone (GH) therapy. Two study cases representing different versions of a digital device were used to facilitate expert panel discussions in the UK and France involving 19 paediatric HCPs. Panel members commented that the new functionalities embodied user-friendly technological progression. The evolution of the easypod device should sustain clinical decision support and enhance personalized approaches to care and management of patients receiving GH therapy.